Amgen Inc. (NASDAQ: AMGN) Price Target and Market Performance

Group 1 - Amgen Inc. is a leading biotechnology company known for its innovative therapies and treatments [1] - The current stock price of Amgen is $367.60, reflecting a decrease of 3.08% or $11.67 [3] - Amgen's market capitalization is approximately $198.16 billion, indicating its significant presence in the biotechnology sector [4] Group 2 - David Risinger from Leerink Partners set a price target of $355 for Amgen, which is currently trading higher at $367.60 [5] - Amgen is scheduled to present at the Leerink Partners 2026 Global Healthcare Conference on March 11, 2026, featuring key executives [2] - The stock has experienced volatility, with a yearly high of $391.29 and a low of $261.43, indicating market fluctuations [5]